Vicplas International Ltd

Informe acción SGX:569

Capitalización de mercado: S$58.8m

Vicplas International Resultados de beneficios anteriores

Pasado controles de criterios 2/6

Vicplas International ha aumentado sus beneficios a una tasa media anual de 2.9%, mientras que los beneficios de la industria de Medical Equipment han experimentado un crecimiento de 11% anual. Los ingresos han ido creciendo a una tasa media de 11.3% al año. La rentabilidad financiera de Vicplas International es de 2.6%, y sus márgenes netos son de 1.7%.

Información clave

2.9%

Tasa de crecimiento de los beneficios

2.7%

Tasa de crecimiento del BPA

Crecimiento de la industria Medical Equipment 16.4%
Tasa de crecimiento de los ingresos11.3%
Rentabilidad financiera2.6%
Margen neto1.7%
Última actualización de beneficios31 Jan 2024

Actualizaciones de resultados anteriores recientes

Recent updates

Does Vicplas International (SGX:569) Have A Healthy Balance Sheet?

Apr 21
Does Vicplas International (SGX:569) Have A Healthy Balance Sheet?

More Unpleasant Surprises Could Be In Store For Vicplas International Ltd's (SGX:569) Shares After Tumbling 25%

Mar 15
More Unpleasant Surprises Could Be In Store For Vicplas International Ltd's (SGX:569) Shares After Tumbling 25%

Returns At Vicplas International (SGX:569) Are On The Way Up

Jan 31
Returns At Vicplas International (SGX:569) Are On The Way Up

Here's Why Vicplas International (SGX:569) Can Manage Its Debt Responsibly

Dec 15
Here's Why Vicplas International (SGX:569) Can Manage Its Debt Responsibly

Does Vicplas International (SGX:569) Have A Healthy Balance Sheet?

Jun 15
Does Vicplas International (SGX:569) Have A Healthy Balance Sheet?

Here's What To Make Of Vicplas International's (SGX:569) Decelerating Rates Of Return

Sep 22
Here's What To Make Of Vicplas International's (SGX:569) Decelerating Rates Of Return

I Ran A Stock Scan For Earnings Growth And Vicplas International (SGX:569) Passed With Ease

May 22
I Ran A Stock Scan For Earnings Growth And Vicplas International (SGX:569) Passed With Ease

Returns At Vicplas International (SGX:569) Appear To Be Weighed Down

May 04
Returns At Vicplas International (SGX:569) Appear To Be Weighed Down

These 4 Measures Indicate That Vicplas International (SGX:569) Is Using Debt Reasonably Well

Apr 16
These 4 Measures Indicate That Vicplas International (SGX:569) Is Using Debt Reasonably Well

Vicplas International Ltd (SGX:569) Stock's On A Decline: Are Poor Fundamentals The Cause?

Mar 11
Vicplas International Ltd (SGX:569) Stock's On A Decline: Are Poor Fundamentals The Cause?

Could The Vicplas International Ltd (SGX:569) Ownership Structure Tell Us Something Useful?

Feb 18
Could The Vicplas International Ltd (SGX:569) Ownership Structure Tell Us Something Useful?

If You Like EPS Growth Then Check Out Vicplas International (SGX:569) Before It's Too Late

Feb 03
If You Like EPS Growth Then Check Out Vicplas International (SGX:569) Before It's Too Late

Is There More To The Story Than Vicplas International's (SGX:569) Earnings Growth?

Jan 19
Is There More To The Story Than Vicplas International's (SGX:569) Earnings Growth?

Here's What To Make Of Vicplas International's (SGX:569) Returns On Capital

Jan 06
Here's What To Make Of Vicplas International's (SGX:569) Returns On Capital

Vicplas International (SGX:569) Has Gifted Shareholders With A Fantastic 194% Total Return On Their Investment

Dec 22
Vicplas International (SGX:569) Has Gifted Shareholders With A Fantastic 194% Total Return On Their Investment

Weak Financial Prospects Seem To Be Dragging Down Vicplas International Ltd (SGX:569) Stock

Dec 07
Weak Financial Prospects Seem To Be Dragging Down Vicplas International Ltd (SGX:569) Stock

Is Vicplas International (SGX:569) Using Too Much Debt?

Nov 22
Is Vicplas International (SGX:569) Using Too Much Debt?

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero Vicplas International. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).


Historial de beneficios e ingresos

SGX:569 Ingresos, gastos y beneficios (SGD Millions)
FechaIngresosBeneficiosGastos G+AGastos de I+D
31 Jan 241192390
31 Oct 231263400
31 Jul 231334410
30 Apr 231365420
31 Jan 231396430
31 Oct 221388430
31 Jul 221379430
30 Apr 2213210410
31 Jan 2212710390
31 Oct 2112310370
31 Jul 2112010360
30 Apr 211119340
31 Jan 211028320
31 Oct 20976300
31 Jul 20925290
30 Apr 20926290
31 Jan 20936290
31 Oct 19885280
31 Jul 19834270
30 Apr 19793260
31 Jan 19753250
31 Oct 18743240
31 Jul 18734240
30 Apr 18713230
31 Jan 18703220
31 Oct 17693210
31 Jul 17673210
30 Apr 17704220
31 Jan 17735220
31 Oct 16765220
31 Jul 16795230
30 Apr 16796230
31 Jan 16786230
31 Oct 15776220
31 Jul 15766210
30 Apr 15743210
31 Jan 1572-1210
31 Oct 1468-2200
31 Jul 1465-4200
30 Apr 1468-3210
31 Jan 1471-2220
31 Oct 13792240
31 Jul 13876270
30 Apr 13888260

Ingresos de calidad: 569 tiene ganancias de alta calidad.

Margen de beneficios creciente: Los actuales márgenes de beneficio(1.7%) de 569 son inferiores a los del año pasado (4.6%).


Análisis del flujo de caja libre vs. Beneficios


Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de 569 han crecido un 2.9% al año en los últimos 5 años.

Acelerando crecimiento: 569 ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.

Beneficios vs. Industria: 569 tuvo un crecimiento negativo de los beneficios (-69%) durante el año pasado, lo que dificulta la comparación con la media de la industria Medical Equipment (-1.5%).


Rentabilidad financiera

Alta ROE: La rentabilidad financiera de 569 (2.6%) se considera baja.


Rentabilidad económica


Rendimiento del capital invertido


Descubre empresas con buenos resultados en el pasado

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target